These results suggest that 68Ga-grazytracer PET detected the high granzyme B secretion of the MC38 tumors but not that of the 4T1 tumors upon ICI therapy on day 6, thereby predicting the tumor responses at an early therapeutic stage. Here, GZMB is linked to neoplasm.